
| Open | 0.00 |
| Previous Close | 125.00 |
| Volume | 0.00 |
| Value (Lacs) | 0.00 |
| VWAP | 0.00 |
| Beta | |
| Mkt Cap (Rs. Cr.) | 138 |
| High | 0.00 |
| Low | 0.00 |
| UC Limit | 131.25 |
| LC Limit | 118.75 |
| 52 Week High | 152.35 |
| 52 Week Low | 88.05 |
| Face Value | 10.00 |
| All Time High | 202.80 |
| All Time Low | 87.10 |
| 20D Avg Volume | 6,660 |
| 20D Avg Delivery(%) | 28.83 |
| Book Value Per Share | 42.67 |
| Dividend Yield | 0.08 |
| TTM EPS See historical trend | 8.39 (-4.34% YoY) |
| TTM PE See historical trend | 14.90 (Average PE) |
| P/B See historical trend | 2.93 (Low P/B) |
| Sector PE | 39.83 |
*Delayed by 20 seconds.
Stock Score
| Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | - - | - - | - - | - - | - - | - - | - - |
| Fibonacci | - - | - - | - - | - - | - - | - - | - - |
| Camarilla | - - | - - | - - | - - | - - | - - | - - |
Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.
| R1 | - - | Pivot - - |
S1 | - - |
| R2 | - - | S2 | - - | |
| R3 | - - | S3 | - - |
Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.
| Days | |
|---|---|
| 5 | - - |
| 10 | - - |
| 20 | - - |
| 50 | - - |
| 100 | - - |
| 200 | - - |
| Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | - - | - - | - - | - - | - - | - - | - - |
| Fibonacci | - - | - - | - - | - - | - - | - - | - - |
| Camarilla | - - | - - | - - | - - | - - | - - | - - |
Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.
| R1 | - - | Pivot - - |
S1 | - - |
| R2 | - - | S2 | - - | |
| R3 | - - | S3 | - - |
Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.
| Days |
|---|
| Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | - - | - - | - - | - - | - - | - - | - - |
| Fibonacci | - - | - - | - - | - - | - - | - - | - - |
| Camarilla | - - | - - | - - | - - | - - | - - | - - |
Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.
| R1 | - - | Pivot - - |
S1 | - - |
| R2 | - - | S2 | - - | |
| R3 | - - | S3 | - - |
Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.
| Days |
|---|
| 1 Week | --% | |
| 1 Month | --% | |
| 3 Months | --% | |
| YTD | --% | |
| 1 Year | --% | |
| 3 Years | --% |
2 out of 3 years Sotac Pharmaceuticals has given negative returns in October.
| Month | Max. Positive Change(%) | Avg. Positive Change(%) | Max. Negative Change(%) | Avg. Negative Change(%) | Average Change(%) |
|---|---|---|---|---|---|
| October | 15.63% | 15.63% | -7.26% (2023) | -6.28% | 1.02% |
Sotac Pharma Consolidated June 2024 Net Sales at Rs 25.25 crore, up 1.13% Y-o-Y Aug 27 2024 12:56 PM
Sotac Pharma Standalone June 2024 Net Sales at Rs 13.01 crore, down 31.18% Y-o-Y Aug 19 2024 09:29 AM
Sotac Pharma Consolidated March 2024 Net Sales at Rs 26.45 crore, up 46.24% Y-o-Y Jun 18 2024 01:15 PM
Sotac Pharma Standalone March 2024 Net Sales at Rs 16.31 crore, up 23.78% Y-o-Y May 29 2024 02:17 PM
*Transaction of a minimum quantity of 500,000 shares or a minimum value of Rs 5 crore.
| Qty 183600 | Price 120 | % Traded 1.62 |
| Qty 183600 | Price 120 | % Traded 1.62 |
| Qty 181200 | Price 93.58 | % Traded 1.65 |
| Qty 181200 | Price 93.58 | % Traded 1.65 |
| Qty 153600 | Price 102.8 | % Traded 1.46 |
| Qty 153600 | Price 102.8 | % Traded 1.46 |
| Qty 99600 | Price 116.3 | % Traded 0.99 |
*A bulk deal is a trade where total quantity of shares bought or sold is more than 0.5% of the equity shares of a company listed on the exchange.
| Date | Agenda |
|---|
| Ex-Date | Type | Dividend (Rs) |
|---|
| Announcement Date | Ex-Bonus | Ratio |
|---|
| Ex-Split | Old FV | New FV |
|---|
| Ex-Right | Ratio | Premium |
|---|
| Date | Agenda |
|---|
| Company Name | Price | % Chg | MCap(Cr) | TTM PE | P/B | ROE(%) | 1 Yr Perform(%) | Net Profit(Rs.) | Net Sales(Rs.) | Debt to Equity |
|---|---|---|---|---|---|---|---|---|---|---|
| Sotac Pharma | 125.00 | - | 138.12 | 28.94 | 2.60 | 8.99 | 1.21 | 4 | 62 | 0.38 |
| Sun Pharma | 1,695.50 | -1.19 | 406,807.24 | 39.22 | 5.63 | 15.13 | -8.46 | 10,980 | 52,578 | 0.03 |
| Divis Labs | 6,672.50 | 2.46 | 177,133.91 | 76.81 | 11.83 | 14.63 | 13.35 | 2,191 | 9,360 | 0.00 |
| Cipla | 1,567.30 | -0.87 | 126,601.12 | 23.48 | 4.46 | 16.90 | 10.51 | 5,291 | 27,547 | 0.00 |
| Torrent Pharma | 3,593.10 | -0.17 | 121,606.83 | 60.75 | 16.20 | 25.17 | 14.51 | 1,911 | 11,516 | 0.40 |